Tycho Peterson
Stock Analyst at JP Morgan
(4.56)
# 342
Out of 4,412 analysts
81
Total ratings
62.5%
Success rate
15.55%
Average return
Main Sectors:
32 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher | Maintains: Overweight | $600 → $650 | $573.60 | +13.32% | 12 | Apr 25, 2024 | |
| AKYA Akoya Biosciences | Maintains: Overweight | $12 → $10 | $3.80 | +163.16% | 2 | Mar 6, 2024 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $270 → $280 | $229.03 | +22.25% | 6 | Feb 15, 2024 | |
| BRKR Bruker | Upgrades: Overweight | $60 → $90 | $80.97 | +11.15% | 3 | Feb 14, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $50 → $52 | $41.65 | +24.85% | 7 | Feb 8, 2024 | |
| RGEN Repligen | Maintains: Overweight | $170 → $210 | $166.58 | +26.07% | 4 | Dec 20, 2023 | |
| ICLR ICON PLC | Maintains: Overweight | $295 → $330 | $308.31 | +7.04% | 2 | Dec 20, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $140 → $165 | $137.74 | +19.79% | 5 | Dec 20, 2023 | |
| WAT Waters | Maintains: Neutral | $260 → $250 | $311.30 | -19.69% | 3 | Nov 8, 2023 | |
| OSUR OraSure Technologies | Maintains: Neutral | $6 → $5 | $5.32 | -6.02% | 2 | Nov 8, 2023 | |
| NVST Envista Holdings | Maintains: Overweight | $42 → $32 | $20.39 | +56.94% | 2 | Nov 2, 2023 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,300 → $1,100 | $1,238.09 | -11.15% | 3 | Oct 17, 2023 | |
| CTLT Catalent | Downgrades: Neutral | $90 → $45 | $55.92 | -19.53% | 1 | May 22, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $11.40 | +57.89% | 2 | Jan 23, 2023 | |
| RPID Rapid Micro Biosystems | Downgrades: Neutral | n/a | $0.95 | - | 2 | Aug 16, 2022 | |
| SEER Seer, Inc. | Downgrades: Neutral | $20 → $12 | $1.91 | +528.27% | 2 | Aug 11, 2022 | |
| QTRX Quanterix | Maintains: Overweight | $85 → $60 | $15.56 | +285.60% | 2 | Mar 2, 2022 | |
| TLIS Talis Biomedical | Downgrades: Underweight | n/a | $9.14 | - | 2 | Sep 27, 2021 | |
| SOPH SOPHiA GENETICS | Initiates: Overweight | n/a | $5.03 | - | 1 | Aug 17, 2021 | |
| OMIC Singular Genomics Systems | Initiates: Overweight | n/a | $0.40 | - | 1 | Jun 21, 2021 | |
| QDEL QuidelOrtho | Maintains: Underweight | n/a | $39.64 | - | 2 | Jun 4, 2021 | |
| TXG 10x Genomics | Maintains: Overweight | n/a | $27.59 | - | 2 | Feb 18, 2021 | |
| TWST Twist Bioscience | Downgrades: Underweight | n/a | $31.54 | - | 1 | Feb 5, 2021 | |
| PACB Pacific Biosciences of California | Upgrades: Overweight | n/a | $1.47 | - | 1 | Oct 2, 2020 | |
| NTRA Natera | Upgrades: Overweight | n/a | $91.66 | - | 1 | May 7, 2020 | |
| ISRG Intuitive Surgical | Maintains: Overweight | n/a | $375.33 | - | 1 | Mar 17, 2020 | |
| HOLX Hologic | Maintains: Overweight | n/a | $75.98 | - | 1 | Mar 17, 2020 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | n/a | $30.57 | - | 4 | Mar 17, 2020 | |
| AXDX Accelerate Diagnostics | Downgrades: Neutral | n/a | $0.93 | - | 1 | Nov 7, 2018 | |
| GH Guardant Health | Initiates: Overweight | n/a | $17.35 | - | 1 | Oct 29, 2018 | |
| IQV IQVIA Holdings | Maintains: Overweight | n/a | $234.88 | - | 1 | Feb 15, 2018 | |
| ARAY Accuray | Downgrades: Underweight | n/a | $2.19 | - | 1 | Dec 13, 2017 |
Thermo Fisher
Apr 25, 2024
Maintains: Overweight
Price Target: $600 → $650
Current: $573.60
Upside: +13.32%
Akoya Biosciences
Mar 6, 2024
Maintains: Overweight
Price Target: $12 → $10
Current: $3.80
Upside: +163.16%
Charles River Laboratories International
Feb 15, 2024
Maintains: Overweight
Price Target: $270 → $280
Current: $229.03
Upside: +22.25%
Bruker
Feb 14, 2024
Upgrades: Overweight
Price Target: $60 → $90
Current: $80.97
Upside: +11.15%
Qiagen
Feb 8, 2024
Maintains: Overweight
Price Target: $50 → $52
Current: $41.65
Upside: +24.85%
Repligen
Dec 20, 2023
Maintains: Overweight
Price Target: $170 → $210
Current: $166.58
Upside: +26.07%
ICON PLC
Dec 20, 2023
Maintains: Overweight
Price Target: $295 → $330
Current: $308.31
Upside: +7.04%
Agilent Technologies
Dec 20, 2023
Maintains: Overweight
Price Target: $140 → $165
Current: $137.74
Upside: +19.79%
Waters
Nov 8, 2023
Maintains: Neutral
Price Target: $260 → $250
Current: $311.30
Upside: -19.69%
OraSure Technologies
Nov 8, 2023
Maintains: Neutral
Price Target: $6 → $5
Current: $5.32
Upside: -6.02%
Envista Holdings
Nov 2, 2023
Maintains: Overweight
Price Target: $42 → $32
Current: $20.39
Upside: +56.94%
Mettler-Toledo International
Oct 17, 2023
Maintains: Neutral
Price Target: $1,300 → $1,100
Current: $1,238.09
Upside: -11.15%
Catalent
May 22, 2023
Downgrades: Neutral
Price Target: $90 → $45
Current: $55.92
Upside: -19.53%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $11.40
Upside: +57.89%
Rapid Micro Biosystems
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.95
Upside: -
Seer, Inc.
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.91
Upside: +528.27%
Quanterix
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $15.56
Upside: +285.60%
Talis Biomedical
Sep 27, 2021
Downgrades: Underweight
Price Target: n/a
Current: $9.14
Upside: -
SOPHiA GENETICS
Aug 17, 2021
Initiates: Overweight
Price Target: n/a
Current: $5.03
Upside: -
Singular Genomics Systems
Jun 21, 2021
Initiates: Overweight
Price Target: n/a
Current: $0.40
Upside: -
QuidelOrtho
Jun 4, 2021
Maintains: Underweight
Price Target: n/a
Current: $39.64
Upside: -
10x Genomics
Feb 18, 2021
Maintains: Overweight
Price Target: n/a
Current: $27.59
Upside: -
Twist Bioscience
Feb 5, 2021
Downgrades: Underweight
Price Target: n/a
Current: $31.54
Upside: -
Pacific Biosciences of California
Oct 2, 2020
Upgrades: Overweight
Price Target: n/a
Current: $1.47
Upside: -
Natera
May 7, 2020
Upgrades: Overweight
Price Target: n/a
Current: $91.66
Upside: -
Intuitive Surgical
Mar 17, 2020
Maintains: Overweight
Price Target: n/a
Current: $375.33
Upside: -
Hologic
Mar 17, 2020
Maintains: Overweight
Price Target: n/a
Current: $75.98
Upside: -
DENTSPLY SIRONA
Mar 17, 2020
Maintains: Neutral
Price Target: n/a
Current: $30.57
Upside: -
Accelerate Diagnostics
Nov 7, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.93
Upside: -
Guardant Health
Oct 29, 2018
Initiates: Overweight
Price Target: n/a
Current: $17.35
Upside: -
IQVIA Holdings
Feb 15, 2018
Maintains: Overweight
Price Target: n/a
Current: $234.88
Upside: -
Accuray
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.19
Upside: -